Friday, October 18, 2013

The Economist sounds alarm on scientific studies

It is tempting to see the priming fracas as an isolated case in an area of science—psychology—easily marginalised as soft and wayward. But irreproducibility is much more widespread. A few years ago scientists at Amgen, an American drug company, tried to replicate 53 studies that they considered landmarks in the basic science of cancer, often co-operating closely with the original researchers to ensure that their experimental technique matched the one used first time round. According to a piece they wrote last year in Nature, a leading scientific journal, they were able to reproduce the original results in just six. Months earlier Florian Prinz and his colleagues at Bayer HealthCare, a German pharmaceutical giant, reported in Nature Reviews Drug Discovery, a sister journal, that they had successfully reproduced the published results in just a quarter of 67 seminal studies The Economist
Scientific studies must be able to be replicated to verify its correctness. However there are growing number of data showing that a lot of them cannot be replicated. Bear in mind also that the effort to replicate a result requires funding and nowadays it is hard to get funding to replicate scientific research.

1 comment:

Jesse said...

a journal article on the topic in medicine.